John Concato

Aug 7, 2023 | ascpt.onlinelibrary.wiley.com | Motiur Rahman |Kimberly Smith |John Concato |Bartholt Bloomfield-Clagett

Brief Report This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1002/cpt.3018. Abstract The US Food and Drug Administration (FDA) is evaluating the potential use of real-world evidence (RWE) in regulatory decision-making.